The role of GDF-15 and its receptor GFRAL in the development and progression of obesity and T2D is well described [12,13,14,16,17,18,19,20], but the molecular mechanisms accounting for the high expression of GDF-15 in these conditions is poorly understood. This evidence concerns the gene GDF15 and obesity disorder.